𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined therapy of the antimetastatic compound NAMI-A and electroporation on B16F1 tumour cells in vitro

✍ Scribed by Ajda Bicek; Iztok Turel; Masa Kanduser; Damijan Miklavcic


Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
284 KB
Volume
71
Category
Article
ISSN
1567-5394

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Separation of lymphoid cells with a supp
✍ N. Schaaf-Lafontaine 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 French ⚖ 487 KB 👁 2 views

## Abstract One or 4 weeks after grafting of a syngeneic sarcoma (T~2~) to C57BL/6 mice, lymph‐node cells (LNC) are cytotoxic __in vitro__ for the cells of this tumour. But after 2 weeks LNC are not cytotoxic or show a non‐significant activity. These second‐week LNC, added to cytotoxic lymphocytes

Hypoxia response element-driven cytosine
✍ Laure Marignol; Ruth Foley; Thomas D. Southgate; Mary Coffey; Donal Hollywood; M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract ## Background We proposed to exploit hypoxia‐inducible factor (HIF)‐1α overexpression in prostate tumours and use this transcriptional machinery to control the expression of the suicide gene cytosine deaminase (CD) through binding of HIF‐1α to arrangements of hypoxia response elements.

The differential effects of the radiopro
✍ Bryan S. Margulies; Timothy A. Damron; Matthew J. Allen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 405 KB

## Abstract The purpose of this study was to determine the differential effects of therapeutic X‐radiation on constituent bone cells relative to the pediatric tumor cells: Ewing's sarcoma of bone and rhabdomyosarcoma. In addition, the radioprotectant drugs amifostine and sodium selenite were admini

The effect of combined application of TG
✍ M. van der Zande; X. F. Walboomers; A. Briest; M. Springer; J. I. Álava; J. A. J 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

## Abstract This study investigated the combined application of Transforming Growth Factor β‐1 (TGFβ‐1) and Bone Morphogenetic Protein‐2 (BMP‐2) to stimulate osteogenic expression __in vitro__. TGFβ‐1 and BMP‐2 fulfill specific roles in the formation of new bone. COLLOSS® E, a bone‐derived collagen